Enhancement of the immunogenicity of an infectious laryngotracheitis virus DNA vaccine by a bicistronic plasmid encoding glycoprotein B and interleukin-18

Antiviral Research

Volumn 87, Issue 2, 2010, Pages 235-241

  Chen, Hong Ying ^a   Zhao, Li ^b   Wei, Zhan Yong ^a   Cui, Bao An ^a   Wang, Zhen Ya ^a   Li, Xin Sheng ^a   Xia, Ping An ^a   Liu, Jin Peng ^a  

^a HENAN AGRICULTURAL UNIVERSITY   (China)

^b ZHENGZHOU COLLEGE OF ANIMAL HUSBANDRY ENGINEERING   (China)

Author keywords

Chicken interleukin 18; DNA vaccine; Eukaryotic expression; Infectious laryngotracheitis virus

Indexed keywords

ANTIBODY; DNA VACCINE; GLYCOPROTEIN B; INTERLEUKIN 18; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GB PROTEIN, INFECTIOUS LARYNGOTRACHEITIS VIRUS; IMMUNOLOGICAL ADJUVANT; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIBODY BLOOD LEVEL; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; ILTOVIRUS; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RECOMBINANT PLASMID; TRACHEITIS; ANIMAL; BLOOD; CHEMISTRY; CHICKEN; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; SURVIVAL; T LYMPHOCYTE SUBPOPULATION;

EUKARYOTA; GALLID HERPESVIRUS 1; GALLUS GALLUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRUS 1, GALLID; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-18; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 77954888776     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.05.009     Document Type: Article

References (39)

1. Barouch D.H. Rational design of gene-based vaccines. J. Pathol. 2006, 208:283-289.
2. Barouch D.H., Letvin N.L., Seder R.A. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol. Rev. 2004, 202:266-274.
3. Chen J.Z., Zhu H.H., Liu K.Z., Chen Z. Enhancing cellular immune response to HBV M DNA vaccine in mice by codelivery of interleukin-18 recombinant. J. Zhejiang Univ. Sci. 2004, 5:467-471.
4. Dinarello C.A., Fantuzzi G. Interleukin-18 and host defense against infection. J. Infect. Dis. 2003, 187:S370-S384.
5. Dufour-Zavala L. Epizootiology of infectious laryngotracheitis and presentation of an industry control program. Avian Dis. 2008, 52:1-7.
6. Fuchs W., Veits J., Helferich D., Granzow H., Teifke J.P., Mettenleiter T.C. Molecular biology of avian infectious laryngotracheitis virus. Vet. Res. 2007, 38:261-279.
7. Gurunathan S., Klinman D.M., Seder R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 2000, 18:927-974.
8. Henke A., Chiang C.S., Zell R., Stelzner A. Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice. Antiviral Res. 2004, 64:131-136.
9. Kalinna B.H. DNA vaccines for parasitic infections. Immunol. Cell Biol. 1997, 75:370-375.
10. Li W.R., Niu B., Wang J.W., Feng Z.J., Wang D.X. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D. Acta Virol. 2006, 50:251-256.
11. Lorenzen N., Lapatra S.E. DNA vaccines for aquacultured fish. Rev. Sci. Tech. 2005, 24:201-213.
12. Marshall D.J., Rudnick K.A., McCarthy S.G., Mateo L.R., Harris M.C., McCauley C., Snyder L.A. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine. Vaccine 2006, 24:244-253.
13. Mingxiao M., Ningyi J., Juan L.H., Min Z., Guoshun S., Guangze Z., Huijun L., Xiaowei H., Minglan J., Xu L., Haili M., Yue J., Gefen Y., Kuoshi J. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18. Antiviral Res. 2007, 76:59-67.
14. Moraes M.P., Chinsangaram J., Brum M.C., Grubman M.J. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 2003, 22:268-279.
15. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001, 12:53-72.
16. Park J.H., Kim S.J., Oem J.K., Lee K.N., Kim Y.J., Kye S.J., Park J.Y., Joo Y.S. Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes. J. Vet. Sci. 2006, 7:257-262.
17. Pollock K.G., Conacher M., Wei X.-Q., Alexander J., Brewer J.M. Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology 2003, 108:137-143.
18. Powell K. DNA vaccines: back in the saddle again?. Nat. Biotechnol. 2004, 22:799-801.
19. Saade F., Buronfosse T., Pradat P., Abdul F., Cova L. Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes. Vaccine 2008, 26:5159-5164.
20. Salagianni M., Wong K.L., Thomas M.J., Noble A., Kemeny D.M. An essential role for IL-18 in CD8 T cell-mediated suppression of IgE responses. J. Immunol. 2007, 178:4771-4778.
21. Schijns V.E. Immunological concepts of vaccine adjuvant activity. Curr. Opin. Immunol. 2000, 12:456-463.
22. Sin J.I., Kim J.J., Arnold R.L., Shroff K.E., McCallus D., Pachuk C., McElhiney S.P., Wolf M.W., Pompa-de Bruin S.J., Higgins T.J., Ciccarelli R.B., Weiner D.B. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. J. Immunol. 1999, 162:2912-2921.
23. Stevenson F.K. DNA vaccines and adjuvants. Immunol. Rev. 2004, 199:5-8.
24. Strugnell R.A., Drew D., Merciece J., DiNatale S., Firez N., Dunstan S.J., Simmons C.P., Vadolas J. DNA vaccine for bacterial infections. Immunol. Cell Biol. 1997, 75:364-369.
25. Sun H.L., Wang Y.F., Tong G.Z., Zhang P.J., Miao D.Y., Zhi H.D., Wang M., Wang M. Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus. Avian Dis. 2008, 52:111-117.
26. Tacket C.O., Roy M.J., Widera G., Swain W.F., Broome S., Edelman R. Phase I safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 1999, 19:2826-2829.
27. Tang M.J., Wang H.N., Zhou S., Tian G.B. Enhancement of the immunogenicity of an infectious bronchitis virus DNA vaccine by a bicistronic plasmid encoding nucleocapsid protein and interleukin-2. J. Virol. Methods 2008, 149:42-48.
28. Thalhamer J., Leitner W., Hammerl P., Brtko J. Designing immune responses with genetic immunization and immunostimulatory DNA sequences. Endocr. Regul. 2001, 35:143-166.
29. Tong G.Z., Zhang S.J., Wang L., Qiu H.J., Wang Y.F., Wang M. Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus. Avian Pathol. 2001, 30:143-148.
30. Tovey M.G., Lallemand C. Adjuvant activity of cytokines. Methods Mol. Biol. 2010, 626:287-309.
31. Wang Y.F., Sun Y.K., Tian Z.C., Shi X.M., Tong G.Z., Liu S.W., Zhi H.D., Kong X.G., Wang M. Protection of chickens against infectious bronchitis by a recombinant fowlpox virus co-expressing IBV-S1 and chicken IFNgamma. Vaccine 2009, 27:7046-7052.
32. Wienhold D., Armengol E., Marquardt A., Marquardt C., Voigt H., Büttner M., Saalmüller A., Pfaff E. Immunomodulatory effect of plasmids co-expressing cytokines in classical swine fever virus subunit gp55/E2-DNA vaccination. Vet. Res. 2005, 36:571-587.
33. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 1990, 247:1465-1468.
34. Xie Z., Li H., Chen J., Zhang H.B., Wang Y.Y., Chen Q., Zhao Z.Z., Cheng C., Zhang H., Yang Y., Wang H.N., Gao R. Shuffling of pig interleukin-2 gene and its enhancing of immunity in mice to Pasteurella multocida vaccine. Vaccine 2007, 25:8163-8171.
35. Xu C., Li Z.S., Du Y.Q., Gong Y.F., Yang H., Sun B., Jin J. Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2. World J. Gastroenterol. 2007, 13:939-944.
36. Yin R.L., Li C., Yang Z.T., Zhang Y.J., Bai W.L., Li X., Yin R.H., Liu H., Liu S., Yang Q., Cao Y.G., Zhang N.S. Construction and immunogenicity of a DNA vaccine containing clumping factor A of Staphylococcus aureus and bovine IL18. Vet. Immunol. Immunopathol. 2009, 132:270-274.
37. Yoon H.A., Aleyas A.G., George J.A., Park S.O., Han Y.W., Lee J.H., Kang H.Y., Kang S.H., Cho J.G., Eo S.K. Modulation of immune responses induced by DNA vaccine expressing glycoprotein B of Pseudorabies Virus via coadministration of IFN-gamma-associated cytokines. J. Interferon Cytokine Res. 2006, 226:730-738.
38. York J.J., Fashey K.J. Vaccination with affinity-purified glycoproteins protects chickens against infectious laryngotracheitis herpesvirus. Avian Pathol. 1991, 20:693-704.
39. Zhang H., Cheng C., Zheng M., Chen J.L., Meng M.J., Zhao Z.Z., Chen Q., Xie Z., Li J.L., Yang Y., Shen Y., Wang H.N., Wang Z.Z., Gao R. Enhancement of immunity to an Escherichia coli vaccine in mice orally inoculated with a fusion gene encoding porcine interleukin 4 and 6. Vaccine 2007, 225:7094-7101.